Background: Adoption of varicella immunization in Europe is limited due to a predicted increase in the incidence of herpes zoster (HZ) resulting from a removal of exogenous boosting by varicella vaccination. Most available assessments of immunization strategies only considered universal varicella vaccination (alone or in combination with HZ by the live vaccine). The development of a new subunit recombinant zoster vaccine may provide new perspectives of HZ control. Methods: We used a mathematical model for VZV in Norway based on the progressive immunity formulation of exogenous boosting. We evaluated a complete range of alternative immunization options against varicella and HZ including both universal and targeted varicella vaccinatio...
Varicella vaccines are highly immunogenic, efficacious and safe in preventing varicella disease. The...
AbstractVaricella vaccines are highly immunogenic, efficacious and safe in preventing varicella dise...
AbstractPurposeVaricella has a high incidence affecting the vast majority of the population in Franc...
Background: Adoption of varicella immunization in Europe is limited due to a predicted increase in t...
Background: Adoption of varicella immunization in Europe is limited due to a predicted increase in t...
<div><p>The introduction of mass vaccination against Varicella-Zoster-Virus (VZV) is being delayed i...
Horn J, Karch A, Damm O, et al. Current and future effects of varicella and herpes zoster vaccinatio...
The introduction of mass vaccination against Varicella-Zoster-Virus (VZV) is being delayed in many E...
The introduction of mass vaccination against Varicella-Zoster-Virus (VZV) is being delayed in many E...
Varicella zoster virus (VZV) is primarily known for causing varicella in childhood, but can reactiva...
Background Norway has not implemented universal varicella vaccination, despite the considerable clin...
Varicella zoster virus (VZV) is primarily known for causing varicella in childhood, but can reactiva...
The introduction of mass vaccination against Varicella-Zoster-Virus (VZV) is being delayed in many E...
Varicella vaccines are highly immunogenic, efficacious and safe in preventing varicella disease. The...
AbstractVaricella vaccines are highly immunogenic, efficacious and safe in preventing varicella dise...
AbstractPurposeVaricella has a high incidence affecting the vast majority of the population in Franc...
Background: Adoption of varicella immunization in Europe is limited due to a predicted increase in t...
Background: Adoption of varicella immunization in Europe is limited due to a predicted increase in t...
<div><p>The introduction of mass vaccination against Varicella-Zoster-Virus (VZV) is being delayed i...
Horn J, Karch A, Damm O, et al. Current and future effects of varicella and herpes zoster vaccinatio...
The introduction of mass vaccination against Varicella-Zoster-Virus (VZV) is being delayed in many E...
The introduction of mass vaccination against Varicella-Zoster-Virus (VZV) is being delayed in many E...
Varicella zoster virus (VZV) is primarily known for causing varicella in childhood, but can reactiva...
Background Norway has not implemented universal varicella vaccination, despite the considerable clin...
Varicella zoster virus (VZV) is primarily known for causing varicella in childhood, but can reactiva...
The introduction of mass vaccination against Varicella-Zoster-Virus (VZV) is being delayed in many E...
Varicella vaccines are highly immunogenic, efficacious and safe in preventing varicella disease. The...
AbstractVaricella vaccines are highly immunogenic, efficacious and safe in preventing varicella dise...
AbstractPurposeVaricella has a high incidence affecting the vast majority of the population in Franc...